According to the Zhitong Finance APP, SINOTHERAPEUTICS (688247.SH) announced that the company's board of directors recently received a written resignation letter from non-independent director and core technical personnel JIANSHENG WAN, who applied to resign from the position of non-independent director of the company's second board of directors and member of the board's strategic development committee due to age reasons, and will no longer serve as the company's core technical personnel. After resignation, JIANSHENG WAN will no longer hold any position in the company.

The company's board of directors also recently received a resignation letter from the company's deputy general manager and core technical personnel LARRY YUN FANG. Due to age reasons, LARRY YUN FANG applied to resign from the position of deputy general manager and will no longer serve as the company's core technical personnel. After resignation, LARRY YUN FANG will continue to hold other positions in the company. At the same time, the company's shareholder Finer Pharma Inc. recommended LARRY YUN FANG as a candidate for non-independent director of the company's second board of directors. After qualification review by the company's board of directors' nomination committee, the company will hold the sixteenth meeting of the second board of directors on April 30, 2025, to review and approve the proposal to nominate LARRY YUN FANG as a candidate for non-independent director of the company's second board of directors. The board agreed to nominate LARRY YUN FANG as a candidate for non-independent director of the company's second board of directors, with a term from the date of approval by the shareholders' meeting until the expiration of the term of the second board of directors. After being elected as a non-independent director, LARRY YUN FANG will serve as a member of the board's strategic and sustainable development committee.

Due to age reasons, non-independent director MAOJIAN GU will no longer participate in the company's specific technical research and development work and will no longer serve as the company's core technical personnel; however, MAOJIAN GU will continue to hold other positions in the company and will continue to serve as a non-independent director of the company's second board of directors and a member of the board's strategic and sustainable development committee.

The company will hold the sixteenth meeting of the second board of directors on April 30, 2025, to review and approve the proposal on the appointment of senior management personnel and financial responsible persons. Based on the nomination by the company's general manager Guo Mingjie and the review and approval by the board's nomination committee, the board agreed to appoint Wu Yiming and Li Fangli as deputy general managers of the company; at the same time, after review and approval by the board's audit committee, the board agreed to appoint Wu Yiming as the company's financial responsible person. Wei Peihua will no longer serve as the company's financial responsible person but will continue to work in the company and be responsible for the specific work of the finance department. Considering the employment history of Shen Qiang and Zhou Haifeng, the company's core technical research and development and technology transfer work needs, and the future contributions to the company's core technical research and development and technology transfer business development, the company's board of directors has newly recognized Shen Qiang and Zhou Haifeng as core technical personnel of the company